Lupus & antiphospholipid syndrome
Vitamin K Antagonists for Pregnant Women With Antiphospholipid Antibodies: A Scoping Review
Authors' conclusion
The current evidence is insufficient to assess VKA efficacy and safety profiles in aPL-positive pregnant patients.
Study context
- Population
- Published research on vitamin K antagonists (VKA) for pregnant patients with aPL17 publications
- Outcome
- Characteristics of published research on VKA in aPL-positive pregnancy
Methodological detailsJoanna Briggs Institute methodology, PRISMA extension for Scoping Reviews
- Joanna Briggs Institute methodology
- PRISMA extension for Scoping Reviews
Main finding
As reported in the abstract
Publications in final analysis (of 1528)
17
VKA-treated aPL-positive pregnancies diagnosed as antiphospholipid syndrome (APS) (up to; likely overlapping)
190
Individuals in comparison groups
723
Publications stating a study objective focusing on VKA use
4
23.5%
Original publication
Vitamin K Antagonists for Pregnant Women With Antiphospholipid Antibodies: A Scoping Review. J Rheumatol. Published 1 August 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →